600873 梅花生物
按盤價 
10.900 +0.680 (+6.654%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 10.420 | 22.985 | 36.432 | 24.316 | 10.872 |
| 總資產報酬率 ROA (%) | 6.451 | 13.352 | 19.381 | 12.019 | 5.127 |
| 投入資產回報率 ROIC (%) | 7.313 | 15.318 | 22.413 | 13.947 | 6.147 | 邊際利潤分析 |
| 銷售毛利率 (%) | 19.501 | 19.681 | 25.133 | 19.406 | 14.671 |
| 營業利潤率 (%) | 13.310 | 13.737 | 18.471 | 12.703 | 6.956 |
| 息稅前利潤/營業總收入 (%) | 12.988 | 13.291 | 18.744 | 13.271 | 7.738 |
| 淨利潤/營業總收入 (%) | 11.657 | 11.459 | 15.772 | 10.526 | 5.897 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 86.526 | 96.746 | 96.008 | 91.576 | 96.838 |
| 價值變動淨收益/利潤總額(%) | 0.968 | -0.819 | 1.107 | 9.915 | -3.946 |
| 營業外收支淨額/利潤總額(%) | 2.012 | -2.424 | -0.143 | -1.596 | -0.656 | 償債能力分析 |
| 流動比率 (X) | 1.237 | 1.456 | 1.486 | 1.354 | 1.062 |
| 速動比率 (X) | 0.856 | 1.009 | 0.876 | 0.819 | 0.637 |
| 資產負債率 (%) | 37.317 | 38.840 | 44.813 | 49.128 | 50.948 |
| 帶息債務/全部投入資本 (%) | 26.766 | 28.287 | 33.076 | 38.454 | 40.801 |
| 股東權益/帶息債務 (%) | 265.091 | 245.454 | 193.365 | 152.614 | 136.928 |
| 股東權益/負債合計 (%) | 167.977 | 157.469 | 123.151 | 103.550 | 93.895 |
| 利息保障倍數 (X) | -21.825 | -110.382 | 62.433 | 17.296 | 9.360 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 8.421 | 6.367 | 4.004 | 4.181 | 6.200 |
| 存貨周轉天數 (天) | 47.988 | 56.437 | 60.763 | 50.502 | 53.890 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
